Literature DB >> 9268153

Infected cell protein 22 of herpes simplex virus 1 regulates the expression of virion host shutoff gene U(L)41.

T I Ng1, Y E Chang, B Roizman.   

Abstract

The U(L)41 protein of herpes simplex virus 1 (HSV-1) is packaged into virions, and in newly infected cells the protein mediates indiscriminate degradation of mRNA, which causes a shutoff of protein synthesis. We report that in cells infected with mutant virus in which either alpha22/U(S)1.5 or U(L)13 had been deleted: (i) the shutoff of protein synthesis and the degradation of mRNA did not take place or were greatly reduced, and consistent with these observations (ii) cells infected with mutant viruses accumulated less U(L)41 mRNA and protein than cells infected with the parent virus; and (iii) purified virions from cells infected with deltaU(L)13 or delta alpha22/deltaU(S)1.5 viruses contained less U(L)41 protein than virions produced by the wild-type parent virus. We conclude that the failure of the U(L)13- mutant virus to shut off protein synthesis immediately after infection is due to the failure of posttranslational modification of infected cell protein 22 and/or the related U(S)1.5 protein by the U(L)13 protein kinase. The regulatory effect of U(L)13 on U(L)41 is indirect and not contingent on direct interaction of this protein with the U(L)41 protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268153     DOI: 10.1006/viro.1997.8659

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present.

Authors:  N S Markovitz; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

3.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

4.  The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.

Authors:  S J Advani; R Brandimarti; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Herpes simplex virus 1 ICP22 regulates the accumulation of a shorter mRNA and of a truncated US3 protein kinase that exhibits altered functions.

Authors:  Alice P W Poon; Bernard Roizman
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.

Authors:  M C Long; V Leong; P A Schaffer; C A Spencer; S A Rice
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus after infection.

Authors:  R Bruni; B Fineschi; W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 8.  The herpes simplex virus type 1 infected cell protein 22.

Authors:  Fu-sen Lin; Qiong Ding; Hong Guo; Alan C Zheng
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

9.  Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.

Authors:  Jenny A Murphy; Rebecca J Duerst; Tracy J Smith; Lynda A Morrison
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Role of herpes simplex virus 1 immediate early protein ICP22 in viral nuclear egress.

Authors:  Yuhei Maruzuru; Keiko Shindo; Zhuoming Liu; Masaaki Oyama; Hiroko Kozuka-Hata; Jun Arii; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.